Epigenetic Gene Networks Governing Immune State Transitions Across the Lifespan.
Key claim: Aging narrows epigenetic transition windows that normally permit reversible immune-state switching, thereby driving chronic inflammation, impaired repair, and neurodegeneration vulnerability as failures of regulated state transition rather than excess signaling alone.
Abstract
Immune function across development, tissue repair, aging, and disease depends not only on signaling pathways but also on epigenetic architectures that determine whether coordinated transcriptional programs can be accessed and resolved. Increasing evidence indicates that epigenetic gene networks regulate the accessibility and reversibility of semi-stable immune states, shaping plastic, homeostatic, reparative, and degenerative configurations. We propose the concept of epigenetic transition windows, defined as temporally and contextually restricted intervals during which epigenetic constraints are relaxed, permitting coordinated and reversible transitions between immune states. During development, these windows are broad and support immune tolerance and adaptive plasticity. In adulthood they become spatially and temporally restricted, preserving stability while enabling conditional adaptation. With aging, they progressively narrow, contributing to chronic inflammation, impaired repair, and increased vulnerability to neurodegeneration. Conversely, pathological persistence of regulatory permissiveness may underlie immune evasion and sustained plasticity in cancer. We outline operational genomic readouts for quantifying transition windows, including chromatin accessibility variance, enhancer switching dynamics, reversibility metrics, and cross-cell coordination indices, and derive experimentally testable predictions that distinguish this model from pathway-centric or damage-centric explanations. By reframing immune dysfunction as a failure of regulated state transition rather than excessive signaling alone, this framework integrates inflammaging, trained immunity, immune resolution failure, and tumor immune escape within a unified regulatory architecture and provides a systems-level perspective on immune adaptability across the lifespan.
Why this matters
The paper repackages inflammaging, trained immunity, resolution failure, and tumor immune escape under one regulatory concept — that aged immune cells lose the epigenetic flexibility to switch states, not merely that they signal too much. If this frame holds, interventions aimed at suppressing cytokine output or clearing senescent cells address downstream symptoms while leaving the underlying state-switching defect intact, and the testable prediction is that reopening transition windows (via chromatin modifiers, partial reprogramming, or trained-immunity induction) should restore reversibility across multiple age-related immune phenotypes. The claim is conceptual and awaits primary data linking specific chromatin features to measurable transition-window width in human aging.